The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: a randomized clinical trial

Archives of Gynecology and Obstetrics

Volumn 291, Issue 6, 2015, Pages 1277-1281

  Shirvani, Marjan Ahmad ^a   Motahari Tabari, Narges ^a   Alipour, Abbas ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ginger; Mefenamic acid; Pain relief; Primary dysmenorrhea

Indexed keywords

MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT;

ANALGESIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECTS; DYSMENORRHEA; FEMALE; GINGER; HUMAN; PAIN; PAIN MEASUREMENT; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RHIZOME; SEVERITY OF ILLNESS INDEX; STUDENT; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSMENORRHEA; FEMALE; GINGER; HUMANS; MEFENAMIC ACID; PAIN; PAIN MANAGEMENT; PAIN MEASUREMENT; PHYTOTHERAPY; PLANT EXTRACTS; RHIZOME; SEVERITY OF ILLNESS INDEX; STUDENTS; TREATMENT OUTCOME;

EID: 84939963008     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3548-2     Document Type: Article

References (42)

1. Abbaspour Z, Rostami M, Najjar S (2006) The effect of exercise on primary dysmenorrhea. J Res Health Sci 6(1):26–31
2. Brown J, Brown S (2010) Exercise for dysmenorrhoea. Cochrane Database Syst Rev 2. doi:10.1002/14651858.CD004142
3. Cakir M, Mungan I, Karakas T, Girisken I, Okten A (2007) Menstrual pattern and common menstrual disorders among university students in Turkey. Pediatr Int 49(6):938–942
4. Lefebvre G, Pinsonneault O, Antao V, Black A, Burnett M, Feldman K et al (2005) Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can 27(12):1117–1146
5. Dawood MY (2006) Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol 108(2):428–441
6. French L (2005) Dysmenorrhea. Am Fam physician 71(2):285–291
7. Pistofidis G, Koukoura DG, Bardis NS, Filippidis M (2010) Laparoscopic treatment of a case of cystic adenomyosis of the lower uterine wall. J Minim Invasive Gynecol 17(6):S97
8. Anaf V, Simon P, Nakadi EI, Fayt I, Buxant F, Simonart T et al (2000) Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod 15(8):1744–1750
9. Abdul-Razzak KK, Ayoub NM, Abu-Taleb AA, Obeidat BA (2010) Influence of dietary intake of dairy products on dysmenorrhea. J Obstet Gynaecol Res 36(2):377–383
10. Reddish S (2006) Dysmenorrhoea. Aust Fam Physician 35(11):842–844, 846–849
11. Cheng HF, Lin YH (2011) Selection and efficacy of self-management strategies for dysmenorrhea in young Taiwanese women. J Clin Nurs 20(7–8):1018–1025
12. Marjoribanks J, Proctor ML, Farquhar C, Derks RS (2010) Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 20(1):CD001751. doi: 10.1002/14651858
13. Bolton PJ, Del Mar C, O’Connor V, Dean LM, Jarrett MS (2012) Exercise for primary dysmenorrhoea. Cochrane Libr. doi:10.1002/14651858
14. Proctor M, Farquhar C (2006) Diagnosis and management of dysmenorrhea. BMJ 332(7550):1134–1138
15. Campbell MA, McGrath PG (1997) Use of medication by adolescents for the management of menstrual discomfort. Arch Pediatr Adolesc Med 151(9):905–913
16. Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M et al (2009) Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol 44(9):879–888
17. Traversa G, Walker AM, Ippolito FM, Caffari B, Capurso L, Dezi A et al (1995) Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology 6(1):49–54
18. Zhu, X, Proctor M, Bensoussan A, Wu E, Smith CA (2008) Chinese herbal medicine for primary dysmenorrhoea. Cochrane Database Syst Rev 16(2):CD005288. doi:10.1002/14651858
19. Proctor M, Murphy PA (2001) Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2:CD002124. doi: 10.1002/14651858
20. Rahnama P, Montazeri A, Huseini HF, Kianbakht S, Naseri M (2012) Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial. BMC Complement Altern Med 12(1):92. doi:10.1186/1472-6882-12-92
21. Terry R, Posadzki P, Watson LK, Ernst E (2011) The use of ginger (Zingiber officinale) for the treatment of pain: a systematic review of clinical trials. Pain Med 12(12):1808–1818
22. Jenabi E (2013) The effect of ginger for relieving of primary dysmenorrhoea. J Pak Med Assoc 63(1):8–10
23. Ozgoli G, Goli M, Moattar F (2009) Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. J Altern Complement Med 15(2):129–132
24. Shahr-jerdy S, Hosseini RS, Gh ME (2012) Effects of stretching exercises on primary dysmenorrhea in adolescent girls. Biomed Human Kinet 4:127–132
25. Altman R, Marcussen K (2001) Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 44(11):2531–2538
26. Mills S, Bone K (2000) Principles and practice of phytotherapy: modern herbal medicine. Churchill Livingstone, Edinburgh
27. Kashefi F, Khajehei M, Cher MT, Alavian M, Asili J (2014) Comparison of the effect of ginger and zinc sulfate on primary dysmenorrhea: a placebo-controlled randomized trial. Pain Manag Nurs. doi:10.1016/j.pmn.2013.09.001
28. Halder A (2011) Effect of progressive muscle relaxation versus intake of ginger powder on dysmenorrhoea amongst the nursing students in Pune. Nurs J India 103(4):152–156
29. Chen CK, Huang YP, Fang HL, Huang YY (2013) Dysmenorrhea: a study of affected factors and approaches to relief among female students at a college in southern Taiwan. Hu li Za Zhi 60(3):40–50
30. Backon J (1991) Mechanism of analgesic effect of clonidine in the treatment of dysmenorrhea. Med Hypotheses 36(3):223–224
31. Kim JK, Kim Y, Na KM, Surh YJ, Kim TY (2007) Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo. Free Radic Res 41(5):603–614
32. Bieglmayer C, Hofer G, Kainz C, Reinthaller A, Kopp B, Janisch H (1995) Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecol Endocrinol 9(4):307–312
33. Grzanna R, Lindmark L, Frondoza CG (2005) Ginger-an herbal medicinal product with broad anti-inflammatory actions. J Med Food 8(2):125–132
34. Ife J, Magowan B (2004) Clinical obstetrics and gynecology. WB Saunders, Edinburgh
35. Kikuzaki H, Nakatani N (1996) Cyclic diarylheptanoids from rhizomes of Zingiber officinale. Phytochemistry 43(1):273–277
36. Schulick P (1996) Ginger: common spice and wonder drug. Herb Free Press, Brattleboro
37. Ali BH, Blunden G, Tanira MO, Nemmar A (2008) Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 46(2):409–420
38. Kim SO, Kundu JK, Shin YK, Park JH, Cho MH, Kim TY et al (2005) Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-κB in phorbol ester-stimulated mouse skin. Oncogene 24(15):2558–2567
39. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sandawa U (1992) Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull 40:187–191
40. Yang JJ, Sun LH, She YF, Ge JJ, Li XH, Zhang RJ (2008) Influence of ginger-partitioned moxibustion on serum no and plasma endothelin-1 contents in patients with primary dysmenorrhea of cold-damp stagnation type. Zhen Ci Yan Jiu 33(6):409–412
41. Nievergelt A, Marazzi J, Schoop R, Altman KH, Gertsch J (2011) Ginger phenylpropanoids inhibit IL-1β and prostanoid secretion and disrupt arachidonate-phospholipid remodeling by targeting phospholipases A2. J Immunol 187(8):4140–4150
42. Blumenthal M, Busse WR, Goldberg A (1998) The complete german commission e monographs: therapeutic guide to herbal medicines. Integrative Medicine, Boston